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Self-reactive T cells can escape thymic deletion and
therefore some of these potentially autoaggressive
T cells need to convert into regulatory T (Treg) cells
to help control responses against self. However, it re-
mains unknown how peripheral self-reactive T cells
are specifically instructed to become Treg cells. We
report that CD5, whose expression is upregulated
in T cells by self and tolerizing antigens in the thymus
and periphery, governed extrathymic Treg cell devel-
opment. CD5 modified effector cell-differentiating
signals that inhibit Treg cell induction. Treg cell con-
version of Cd5/ and CD5lo T cells was inhibited by
even small amounts of interleukin-4 (IL-4), IL-6, and
interferon-g (IFN-g) produced by bystander lympho-
cytes, while CD5hi T cells resisted this inhibition of
Treg cell induction. Our findings further revealed
that CD5 promoted Treg cell induction by blocking
mechanistic target of rapamycin (mTOR) activation.
Therefore CD5 instructs extrathymic Treg cell devel-
opment in response to self and tolerizing antigens.
INTRODUCTION
To prevent an attack against self-proteins, the immune system
uses several mechanisms of tolerance including a development
of thymic regulatory T cells (tTreg cells) (Josefowicz et al.,
2012a; Mathis and Benoist, 2009; Sakaguchi et al., 2013; von
Boehmer andMelchers, 2010). Further, extrathymic T cells might
differentiate into peripheral (p)Treg cells in response to different,
often contradictory, environmental signals received by individual
immune cells (Arpaia et al., 2013; Dardalhon et al., 2008; Fran-
cisco et al., 2010; Hadjur et al., 2009; Josefowicz et al., 2012a;
Josefowicz et al., 2012b; Luo and Li, 2013; Zhou et al., 2009).
However, it remains unknown how the self-reactive T cells might
be specifically instructed to convert into pTreg cells to help pro-
vide an antigen-specific and long-lasting tolerance.
During thymic T cell development, CD5 expression parallels
T cell receptor (TCR) signal strength in thymocytes: high-avidity
interactions of self-peptide-major histocompatibility complex
(self-pMHC) with thymocytes bearing high affinity TCR for self-
antigens lead to increased CD5 expression in developing CD4+T cells (Azzam et al., 1998). By negatively regulating specific
signaling pathways induced by TCR activation in developing thy-
mocytes, CD5 influences the threshold for T cell activation and
selection thereby helping to spare highly responsive T cells
from deletion (Azzam et al., 2001; Azzam et al., 1998; Tarakhov-
sky et al., 1995). Such elevated CD5 expression persists in
mature peripheral T cells (Kassiotis et al., 2003; Mandl et al.,
2013; Stritesky et al., 2012). Recently published reports further
confirmed that the CD5 expression distinguishes self-reactive
cells in the peripheral CD4+ T cell polyclonal repertoire (Mandl
et al., 2013; Persaud et al., 2014). Despite the CD5 functions
that decrease TCR-signaling in thymocytes, the peripheral
CD5hi T cells remain responsive to antigenic stimulation and
both CD5lo and CD5hi T cells can give rise to effector cells
cross-reactive to epitopes from foreign pathogens (Azzam
et al., 2001; Mandl et al., 2013; Persaud et al., 2014). Therefore,
despite harboring self-reactive cells, the CD5hi T cell population
actively contributes to specific immune responses. This raises a
question how the potentially autoaggressive cross-reactive re-
sponses against self might be prevented.
Some CD5lo cells also respond to peripheral self-antigens and
therefore could contribute to autoimmune responses (Klein et al.,
2014). However, in response to antigens presented by peripheral
tolerogenic dendritic cells (DCs), the CD5lo cells induce high CD5
expression in an immune tolerance-associated process (Ha-
wiger et al., 2004). Therefore, an increased expression of CD5
in peripheral T cells can result from previous high-avidity re-
sponses to self-pMHC in thymus or tolerizing antigens in the
periphery.
Consistent with CD5 expression correlating with TCR signal
strength in thymus, expression of CD5 is also increased in regu-
latory T cells (Barthlott et al., 2003; Dasu et al., 2008; Ordon˜ez-
Rueda et al., 2009; Verhoef et al., 2005). However, CD5 is not
required for thymic development of tTreg cells (Ordon˜ez-Rueda
et al., 2009). Nevertheless, a common peripheral CD4+ T cell pre-
cursor for naive, memory, and regulatory T cells expresses CD5
(Zhao and Davies, 2010). On the basis of a shared high expres-
sion of CD5 in Treg cells and the conventional CD5hi T cells re-
sponding to self or tolerizing antigens, we hypothesized that
CD5 governs a process of extrathymic Treg cell development.
Here we show that CD5 directly promotes Treg cell induction
by blocking activation of mechanistic target of rapamycin
(mTOR) and resisting the inhibition of Treg cell induction by
effector cell-differentiating cytokines including interleukin-4
(IL-4), IL-6, and interferon-g (IFN-g). We propose a model
whereby following responses to either self-pMHC in thymus orImmunity 42, 471–483, March 17, 2015 ª2015 Elsevier Inc. 471
tolerizing antigens in periphery, T cells upregulate their CD5
expression and in such T cells CD5 instructs extrathymic Treg
cell development by specifically modulating responses to sig-
nals affecting T cell differentiation to prevent subsequent auto
immune responses. In contrast, a conversion into Treg cells of
CD5lo T cells, which are not reactive to self or innocuous periph-
eral antigens but insteadmight be specific for foreign pathogens,
is decreased in the absence of CD5 functions.
RESULTS
CD5 Promotes Efficient Induction of Extrathymic Treg
Cells by Resisting Effector Cell-Mediated Inhibition of
Foxp3 Induction
To examine a role of CD5 in de novo induction of Treg cells, we
first examined in vitro induction of Foxp3-expressing cells from
B6 polyclonal Cd5+/+ and Cd5/ CD4+ cells and found
increased numbers of Foxp3+ cells among Cd5+/+ T cells (Fig-
ure S1A). Polyclonal peripheral T cells differ in CD5 expression
reflecting TCR affinities to self (Azzam et al., 1998; Klein et al.,
2014; Persaud et al., 2014; Soldevila et al., 2011; Tarakhovsky
et al., 1995). To directly compare the impact of either high,
low, or absent CD5 expression in T cells on their Treg cell conver-
sion, we divided the B6 polyclonal T cells into CD5hi and CD5lo
populations by cell sorting and cultured the CD5hi, CD5lo, and
Cd5/ CD4+ cells under Treg cell-differentiation conditions us-
ing various concentrations of transforming growth factor-b
(TGF-b). We observed that at all tested concentrations of
TGF-b, CD5hi T cells converted into Foxp3+CD25+ iTreg cells
about twice as efficiently as the CD5lo or Cd5/ T cells and
the Treg cell induction among CD5lo orCd5/ T cells was nearly
identical (Figure 1A). In all experiments, we observed similar re-
covery of viable cells among all groups (Figure S1). In a separate
experiment, we confirmed that the presence of anti-CD5 anti-
body used for examining CD5 expression in Cd5+/+ T cells did
not affect the induction of Foxp3 expression in T cells cultured
in vitro (Figure S1B). To examine a role of CD5 in vivo, we
analyzed the expression of Neuropilin 1 (Nrp1) whose expression
is known to be lower in the peripherally induced pTreg cells than
in tTreg cells (Weiss et al., 2012; Yadav et al., 2012). We found a
smaller percentage of Nrp1loFoxp3+ pTreg cells among the in-
testinal lamina propria CD4+ T cells in the Cd5/ B6 mice than
in Cd5+/+ B6 mice, while the percentages of Nrp1hiFoxp3+ Treg
cells and numbers of CD4+ T cells were similar in both Cd5/
and Cd5+/+ mice and Cd5+/+ pTreg cells displayed high expres-
sion of CD5 (Figures 1B–1D and Figures S1E and S1F). We
conclude that CD5 expression in T cells preferentially skews in-
duction of Treg cells both in vitro and in vivo.
CD4+ T cells consist of heterogeneous populations of pre-acti-
vated CD44hiCD62lo effector and CD44loCD62hi naive cells that
can differentiate into multiple T cell subsets (Zhou et al., 2009)
The frequencies of these populations were similar among
Cd5+/+ andCd5/CD4 T cells (Figure S1C). Therefore, to further
examine roles of CD5 in Treg cell conversion, we tested the in-
duction of iTreg cells from B6 polyclonal CD5hi, CD5lo, and
Cd5/ naive T cells (Figure 1E). We observed that all groups
of naive T cells converted into iTreg cells with a similar high effi-
ciency at various concentrations of TGF-b (Figure 1E). Therefore
naive CD5hi, CD5lo, and Cd5/ T cells do not differ in their472 Immunity 42, 471–483, March 17, 2015 ª2015 Elsevier Inc.intrinsic ability to convert into Treg cells, inconsistent with altered
sensitivity to TGF-b or other intrinsic differences among CD5hi,
CD5lo, and Cd5/ naive cells. Instead, those results suggested
that CD5 possiblymodulates the effectsmediated in naive T cells
by the bystander cell populations such as effector T cells that
can inhibit Treg cell induction (Hill et al., 2008).
To test this hypothesis, we co-cultured various groups of
CD5hi, CD5lo, and Cd5/ naive T cells with CD45.1-congeni-
cally-labeled effector T cells. We observed that in the presence
of effector T cells induction of Treg cells in the CD5lo or Cd5/
groups was reduced by about half compared to Treg-conversion
among CD5hi naive T cells (Figure 1F). Similar results were ob-
tained with Cd5/ effector cells, further suggesting specific ef-
fects of CD5 in naive T cells (Figure 1F). We conclude that CD5
programs induction of Treg cells by altering the responsiveness
of naive T cells to specific signals received from bystander
effector cells.
The cell-autonomous functions of CD5 in T cells are indepen-
dent of CD5 engagement by a specific ligand but interactions be-
tween CD5 and its putative partners might lead to signaling
through such receptors present on Cd5/ T cells to possibly
promote Treg cell induction (Bhandoola et al., 2002; Brown
and Lacey, 2010; Fenutrı´a et al., 2014; Zheng et al., 2014). We
co-cultured Cd5/ naive T cells in the presence of exceeding
numbers of congenically-labeled Cd5+/+ T cells. We observed
no impact on Cd5/ Treg induction by neighboring Cd5+/+ cells
consistent with the absence of relevant cell-autonomous CD5
functions in Cd5/ T cells (Figure 1G).
CD5 Is Required for Induction of Antigen-Specific
Regulatory T Cells Mediating Peripheral Tolerance
To extend our observations in vivo, we used T cells of defined an-
tigen specificity. Similar to some other TCR transgenic T cells,
CD4+ T cells from anti-MOG TCR tg (2D2) mice are characterized
by a narrow distribution of CD5 expression as a consequence of
a fixed and lower affinity of their TCR in comparison to B6 poly-
clonal T cells (Bettelli et al., 2003; Mandl et al., 2013; Persaud
et al., 2014; Figure S2A). In response to MOG antigen presented
by tolerizing DCs, such 2D2 T cells upregulate their expression of
CD5 in a mechanism that appears analogous to a thymic in-
crease in CD5 expression following high-avidity activation (Ha-
wiger et al., 2004). Because DCs can also induce pTreg cells
(Kretschmer et al., 2005), we hypothesized that these CD5hi
T cells might then convert into pTreg cells in a CD5-dependent
process. To test this, we first transferred sorted, Foxp3neg
CD25neg 2D2 T cells into CD45.1 congenic recipient mice. We
treated recipients with aDEC-MOG, a chimeric antibody that de-
livers myelin oligodendrocyte glycoprotein (MOG) peptide to
DCs as a fusion protein linked to the C terminus of the antibody
heavy chain, resulting in presentation of MOG to T cells (Hawiger
et al., 2001; Hawiger et al., 2004). In agreement with our previ-
ously published results (Hawiger et al., 2004), we found that
3 days after a delivery of MOG to DCs, 86% of the transferred
CD4+ cells became CD5hi. Furthermore, by 9 days, about 20%
of all transferred CD4+ cells acquired Foxp3 expression and a
majority of these Foxp3+ cells were characterized by increased
expression of CD5 (Figure 2A). We conclude that an increased
expression of CD5, induced in response to peripheral tolero-
genic antigens, precedes a conversion into Foxp3+ pTreg cells.
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Figure 1. Sufficient CD5 Expression Promotes Efficient Induction of Extrathymic Treg Cells in Presence of Effector T Cells
(A) CD5 promotes induction of regulatory T cells ex vivo. Foxp3negCD25neg CD4+ T cells were isolated by sorting from Cd5+/+ Foxp3RFP and Cd5/ Foxp3RFP
mice. CD5hi and CD5lo cells were further separated as shown in the histogram (inset). CD5hi, CD5lo, and Cd5/ cells were then cultured under Treg cell dif-
ferentiation conditions. Graph shows percentages of Foxp3+CD25+ cells as indicated.
(B) CD5 induces Foxp3+Nrp1lo pTreg cells in vivo. Plots show intestinal lamina propria lymphocytes analyzed by flow cytometry, Foxp3 (RFP) expression (y axis)
and anti-Nrp1 staining intensity (x axis) gated on CD4+ T cells. Results represent one of four similar experiments.
(C and D) Numbers of Foxp3+Nrp1lo (C) and Foxp3+Nrp1Hi (D) Treg cells shown as percent of total CD4+ cells isolated as in (B). Results are mean ± SD, N = 7 in
each group, *p < 0.02 determined by Student’s t test.
(E) Conversion of isolated naive T cells into Treg cells is independent of CD5. CD5hi, CD5lo, andCd5/CD44loCD62hi (naive) Foxp3negCD25neg cells CD4+ T cells
were isolated and cultured under Treg cell-differentiation conditions. Graph shows percentages of converted Foxp3+CD25+ cells as indicated.
(F) Treg cell induction in the presence of effector cells. CD5hi, CD5lo, and Cd5/ naive cells and total Foxp3negCD25neg cells were cultured under Treg cell-
differentiation conditions in the absence or presence ofCd5+/+ andCd5/CD45.1 congenically labeled effector cells (ratio of naive cells to effector cells was 5:1).
Graph shows percentages of CD45.2+ Foxp3+CD25+ T cells converted from the indicated populations. (A, E, and F) Results are mean ± SEM from three in-
dependent experiments. n.s. p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 determined by two-way ANOVA with multiple comparisons
determined by Tukey’s Test.
(G) The Treg cell-inducing functions of CD5 are cell autonomous. CD45.2+Cd5/ naive cells were co-cultured with CD45.1+Cd5+/+ naive cells in indicated ratios
under Treg cell-differentiation conditions and in either absence or presence of the CD45.1+Cd5+/+ effector cells (ratio of total naive cells to effector cells was 4:1).
Plots show cells analyzed by flow cytometry, Foxp3 (RFP) expression (y axis), and anti-CD25 staining intensity (x axis) gated on CD45.2+ Cd5/ cells. Results
represent one of three similar experiments. (B and G) Numbers in quadrants indicate corresponding percentages.To directly examine the role of CD5 in the development of
Foxp3+ pTreg cells in vivo, we compared a conversion of
Cd5+/+ and Cd5/ 2D2 CD4+ cells into pTreg cells in response
to MOG presented by DCs. The Cd5+/+ and Cd5/ 2D2 CD4+cells share a similar expression of TCR alpha and beta chains,
and they responded similarly to MOG antigen presented by
DCs (Figures S2B and S2C). However, Cd5+/+ and Cd5/ cells
differed in their conversion into pTreg cells. Already 5 daysImmunity 42, 471–483, March 17, 2015 ª2015 Elsevier Inc. 473
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Figure 2. CD5 Is Required for Induction of Antigen-Specific Regulatory T Cells Mediating Peripheral Tolerance
(A) Increased expression of CD5 in T cells precedes an induction of pTreg cells. Foxp3negCD25neg T cells were isolated from 2D2 TCR tg Foxp3RFPmice and then
adoptively transferred into CD45.1+ recipient mice treated with 15 mg/mouse aDEC-MOG or PBS either 3 (day3) or 9 (day9) days before analysis. Plots show
lymph node cells analyzed by flow cytometry, Foxp3 (RFP) expression (y axis), and anti-CD5 staining intensity (x axis) gated on populations of adoptively
transferred CD4+ cells. Results represent one of three similar experiments.
(B) Proliferation in vivo. Cd5+/+ and Cd5/ CFSE-labeled 2D2 TCR tg Foxp3negCD25neg T cells were adoptively transferred into recipients treated with aDEC-
MOG or PBS. Plots show lymph node cells, Foxp3 (RFP) intensity (y axis), and CFSE dilution (x axis) gated on populations of adoptively transferred CD4+ cells
after 5 days. Results represent one of two similar experiments.
(C) Induction of regulatory T cells in vivo requires CD5.Cd5+/+ andCd5/ 2D2 TCR tg Foxp3negCD25neg T cells were adoptively transferred into recipients treated
as in (B). Plots show lymph node cells analyzed by flow cytometry after 11 and 21 days, Foxp3 (RFP) expression (y axis) and anti-CD25 staining intensity (x axis)
gated on populations of adoptively transferred CD4+ T cells. Results represent one of two similar experiments. (A–C) Numbers in quadrants indicate corre-
sponding percentages.
(D) Numbers of pTreg cells shown as percent of total CD4 cells in vivo. Cells were transferred and recipient mice treated as in (C). Graphs show pTreg cells
converted after 11 days as indicated presented as percentages among the total CD4+ cells in the individual recipients. N = 3–4 in each group, **p < 0.01
determined by Student’s t test. Results are mean ± SEM.
(legend continued on next page)
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following a delivery of MOG, about 5% of Cd5+/+ cells induced
Foxp3 expression, and within 21 days most of such transferred
Cd5+/+ T cells became pTreg cells. In contrast fewer than 2%
of transferred Cd5/ CD4+ cells became pTreg cells even after
21 days despite their activation and proliferation that was similar
to Cd5+/+ T cells (Figures 2B–2D). Cumulatively, these results
suggest that CD5 is required for an initiation of pTreg cell induc-
tion in T cells responding to peripheral antigens.
Presentation of MOG to T cells by peripheral DCs prevents
experimental acute encephalomyelitis (EAE) induced by a
subsequent immunization with MOG35–55 and CFA (Hawiger
et al., 2004). However, the role of CD5 in tolerance preventing
antigen-specific autoimmunity was never examined directly in
CD5-deficient animals (Hawiger et al., 2004; Soldevila et al.,
2011). Recent results showed that Treg cells mediate tolerance
preventing EAE (Idoyaga et al., 2013; Stern et al., 2010; Yogev
et al., 2012). Induction of pTreg cells by DCs in vivo allows us
to examine the tolerogenic roles of CD5 by focusing on pTreg
cells rather than tTreg cells whose functions might be increased
in the absence of CD5 (Dasu et al., 2008; Ordon˜ez-Rueda et al.,
2009). Cd5/ mice remain susceptible to EAE though the
severity of EAE is reduced because of decreased encephalito-
genic functions of effector T cells in Cd5/ animals (Axtell
et al., 2006; Sestero et al., 2012). We therefore compared a dif-
ference in the efficacy of pre-treatment with either aDEC-MOG
or PBS on induced EAE severity in the separate groups of
Cd5+/+ and Cd5/ mice. As expected, pre-treatment of
Cd5+/+ mice with aDEC-MOG reduced symptoms of subse-
quently induced EAE and also limited the infiltration of spinal
cords by T cells (Figure 2E). This tolerance depended on Treg
cells because a Treg cell depletion during the formation of anti-
gen-specific pTreg cells completely abolished resistance to the
subsequently induced EAE (Figure S2D). Consistent with the
lack of induction of Cd5/ pTreg cells (Figure 2C), aDEC-
MOG-treated Cd5/ mice developed EAE symptoms and
T cell infiltrations of their spinal cords almost identical to the
Cd5/ mice that were not tolerized (Figure 2F). We conclude
that CD5 is required for antigen-specific tolerance to prevent
induced autoimmune responses.
High CD5 Expression Relieves Inhibition of Treg Cell
Induction by Effector Cell-Differentiating Cytokines
Soluble cytokines, including IL-4, IL-6, or IFN-g, produced by im-
mune cells facilitate effector T cell development and inhibit in-
duction of Treg cells (Dardalhon et al., 2008; Hadjur et al.,
2009; Josefowicz et al., 2012a; Luo and Li, 2013; Zhou et al.,
2009). To measure the impact of CD5 on the reduction of iTreg
cell differentiation in the presence of soluble factors, we added
supernatants from effector T cell cultures to the CD5hi, CD5lo,
and Cd5/ naive B6 polyclonal T cells cultured under in vitro
iTreg cell-differentation conditions. Whereas about 90% of
CD5hi, CD5lo, and Cd5/ naive T cells converted to iTreg cells,(E and F) CD5 is required for antigen-specific tolerance that prevents the inductio
either 15 mg/mouse aDEC-MOG (grey lines) or PBS (black lines) 6 weeks before im
EAE scores presented as linear regression (N = 8–11mice per group from two exp
graphs demonstrate a difference in the CD4+ T cell infiltration in spinal cords 20 da
mean percentages of CD4+ T cells in spinal cord cell suspensions. Results are
obtained in mice pre-treated with PBS (the values set to 1), ***p < 0.001 determithe addition of supernatants decreased the induction of iTreg
cells to 35%–45% in the CD5lo and Cd5/ naive cells, while
iTreg cell conversion remained about 65% in the CD5hi cells (Fig-
ure 3A). To confirm the specific role of soluble cytokines present
in these supernatants, we treated supernatants with cytokine-
neutralizing antibodies. We found that treatment with multiple
cytokine-blocking antibodies completely restored the induction
of Treg cells to 90% in all groups, although neutralization of no
single cytokine was fully effective (Figure 3A). These results sug-
gested that CD5 opposed cytokine-mediated inhibition of Treg
cell induction.
To directly examine CD5-mediated modulation of the specific
impacts of individual cytokines on induction of Treg cells, we
used varying concentrations of recombinant IL-4, IFN-g, and
IL-6. As expected, each of these cytokines inhibited induction
of iTreg cells in a dose-dependent manner (Dardalhon et al.,
2008; Hadjur et al., 2009; Josefowicz et al., 2012a; Luo and Li,
2013; Zhou et al., 2009). In the presence of individually added
IL-4, IFN-g, and IL-6, we observed about 20%–35% decrease
in iTreg cell conversion among CD5lo and Cd5/ cells
compared to the CD5hi cells (Figure 3B–3D). Induction of iTreg
cells from CD5hi cells remained more efficient even at earlier
time points during in vitro cultures andwe also observed a similar
proliferation and viability of such iTreg cells, further supporting
the specific impact of CD5 on initial iTreg cell induction (Figures
3E, S3B, and S3D–S3I). To examine whether upregulation of
CD5 expression affected iTreg cell induction, we induced CD5
expression in CD5lo cells by pre-stimulating them with aCD3
and aCD28. A pre-stimulation of CD5lo cells that increased their
CD5 expression also increased their conversion to iTreg cells;
however, a pre-stimulation of the Cd5/ cells did not signifi-
cantly increase their Treg cell induction (Figure S3J). Collectively,
our results suggest that CD5 expression regulates the initiation
of Treg cell induction in the presence of effector cell-differenti-
ating cytokines. In contrast, CD5 did not alter the skewing by
effector cell-differentiating cytokines into T helper-1 (Th1), Th2,
and Th17 cells (Figures S3A and S3C).
Inhibition of mTOR in the Absence of CD5 Functions
Restores Induction of Treg Cells after Exposure to
Effector Cell-Differentiating Cytokines
To investigate the molecular mechanism of CD5, we first exam-
ined the expression of specific cytokine receptors on naive
T cells and found them to be independent of CD5 expression
(Figure S4A). We also examined the impact of CD5 on STAT3
activation in response to IL-6 and found a similar phosphoryla-
tion of STAT3 in CD5hi, CD5lo, and Cd5/ T cells responding
to IL-6, further suggesting an unaltered proximal cytokine
signaling (Figure 4A). Because an altered TCR signaling in
the absence of CD5 could interfere with the induction of
Treg cells (Azzam et al., 2001; von Boehmer and Melchers,
2010), we examined an impact of TCR activation strength onn of EAE. Multiple groups of Cd5+/+ (E) and Cd5/ mice (F) were treated with
munization with MOG35–55 in CFA + Pertussis Toxin (PT). Linear graphs show
eriments), with dotted lines representing the 95% confidence interval (C.I.). Bar
ys after induction of EAE inCd5+/+ andCd5/mice shown as a relative ratio of
mean ± SEM (n = 4–7 per group from two experiments) normalized to results
ned by Student’s t test.
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Figure 3. High CD5 Expression Relieves Inhibition of Treg Cell Induction by Effector Cell-Differentiating Cytokines
(A) High CD5 expression relieves the inhibition of Treg cell induction mediated by soluble factors. CD5hi, CD5lo and Cd5/ naive CD4+ cells were cultured under
Treg cell-differentiation conditions and in either the absence or presence of supernatants from effector CD4+ cell cultures that were either treated or not treated
with the indicated cytokine-neutralizing antibodies. Graphs show percentages of converted Foxp3+CD25+ cells as indicated.
(B–D) HighCD5 expression relieves the inhibition of Treg cell inductionmediated by individual cytokines. CD5hi, CD5lo, andCd5/CD4+ naive cells were cultured
in vitro for 5 days under Treg cell-differentiation conditions and in either the absence or presence of varying concentrations of recombinant IL-4 (B) IFN-g (C) and
IL-6 (D) as indicated. Graphs show percentages of converted Foxp3+CD25+ cells as indicated.
(E) CD5 promotes induction of Treg cells at early and late time-points. CD5hi, CD5lo, andCd5/ naive CD4+ cells were cultured in vitro for either 3 or 5 days under
Treg cell-differentiation conditions and in either the absence or presence of recombinant IL-6 (8 ng/mL) as indicated. Graphs show percentages of converted
Foxp3+CD25+ cells as indicated. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 determined by two-way ANOVA with multiple comparisons determined by
Tukey’s Test. Results represent mean ± SEM from three (B–D) or two (A and E) independent experiments.
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CD5-dependent promotion of Treg cell induction (Figure 4B).
Within a broad range of TCR stimulation, IL-6mediated a specific
inhibition of Treg cell induction in the absence of CD5 functions
(Figure 4B). Consistently, we found that inefficient conversion of
Cd5/ 2D2 T cells into pTreg cells in vivo was not altered by
decreasing the amount of MOG antigen delivered to DCs (Fig-
ure 4C). Cumulatively, these results suggested a regulation by
CD5 of cytokine signaling through an impact on downstream
signaling pathways (McGuire et al., 2014; Perez-Villar et al.,
1999; Sen et al., 1999; Sestero et al., 2012). To identify pathways
possibly involved in the CD5-dependent promotion of Treg
cell-conversion, we screened several relevant pharmacological
inhibitors. We observed that treatment with rapamycin, an
mTOR inhibitor, most effectively restored induction of iTreg cells
in Cd5/ cells differentiated in the presence of IL-6, and also
similar results were obtained with wortmannin, an inhibitor of
phosphatidylinositol-3-kinase (PI3K) (Figure 4D). This result is
consistent with the role of PI3K to induce mTOR, which inhibits
Treg cell differentiation and functions of CD5 to inhibit PI3K acti-
vation in T cells (Delgoffe et al., 2009; Haxhinasto et al., 2008;
Kang et al., 2008; Powell et al., 2012; Sauer et al., 2008; Soldevila
et al., 2011; Thomson et al., 2009).
Consistent with signaling through cytokine receptors that in-
duces activation of PI3K and mTOR leading to activation of
downstream target molecules such as p70 S6 kinase (S6K) (Car-
doso et al., 2009; Fang et al., 2006; Kim et al., 2013; Powell et al.,
2012), we found an increased phosphorylation of S6K after stim-
ulation with IL-6 in the absence of CD5 (Figure 4E). We then
examined a phosphorylation of S6 (at S235 and 236), a target
of S6K, either 2 or 3 hr after the initial stimulation with effector
differentiating cytokines. Further consistent with a specific
impact of CD5 on S6K activation, we found an increased
phosphorylation of S6, in the absence of CD5 functions
after stimulation with IL-6 (Figure 4F), as well as IL-4 and IFN-g
(Figure S4C). Consistent with the regulation of PI3K by CD5,
we also found some increased mTOR-dependent phos-
phorylation at Ser473 and a phosphoinositide-dependent kinase
1 (PDK1)-dependent phosphorylation at Thr308 of Akt (Fig-
ure S4B). To verify an impact of a specific regulation of mTOR
by CD5 on iTreg cell differentiation, we added rapamycin to
the CD5hi, CD5lo, and Cd5/ naive CD4 T cells that were differ-
entiated to Treg cells in the presence of the supernatants from
effector T cell cultures (Figure 4G). Addition of rapamycin almost
doubled the induction of Treg cells in the CD5lo and Cd5/
groups, whereas a corresponding increase in a conversion to
iTreg cells among CD5hi cells was only about one-fourth (Fig-
ure 4G). We conclude that CD5 opposes mTOR activation in
developing Treg cells exposed to effector cell differentiating
cytokines.
High Expression of CD5 in T Cells Blocks mTOR-
Mediated Inhibition of Treg Cell Induction
To further examine whether CD5-dependent inactivation of
mTOR blocks a cytokine-mediated inhibition of Treg cell induc-
tion, we used naive CD4 T cells from Cd4cre-Mtorfl/fl (Mtor/)
mice and Mtor+/+ mice also crossed with Cd5/ and Foxp3RFP
reporter animals (Figures 5A–5C). We observed a similarly effi-
cient (85%–95%) induction of Treg cells in all groups of Mtor+/+
andMtor/ cells cultured without the added effector cell-differ-entiating cytokines and among CD5hi cells induction of Treg cells
remained at 65%–80% in the presence of either IL-4, IL-6, or
IFN-g (Figures 5A–5C). As expected, we observed among the
Cd5/ Mtor+/+ cells cultured in the presence of either IL-4 or
IL-6 a reduced Treg induction to about 55% and 30% respec-
tively. In contrast, in Cd5/ Mtor/ cells cultured under same
conditions, the Treg cell induction remained at about 70% and
60% in the presence of, correspondingly, IL-4 and IL-6 (Figure 5A
and B). We also observed a higher (60%) Treg cell induction in
CD5lo Mtor/ cells cultured in the presence of IL-6 when
compared to the 40% induction among CD5lo Mtor+/+ cells (Fig-
ure 5B), and also a small (about 15%) difference in conversion to
Treg cells among the Cd5/Mtor/ andMtor+/+ cells differen-
tiated in the presence of IFN-g (Figure 5C). We conclude that
CD5 blocks mTOR-dependent inhibition of Treg cell induction
in response to effector cell-differentiating cytokines, particularly
IL-4 and IL-6.
To confirm a role of CD5 in negative regulation of mTOR during
the in vivo induction of pTreg cells, we compared the conversion
of Cd5+/+ and Cd5/ 2D2 sorted Foxp3negCD25neg CD4+ cells,
either Mtor+/+ or Mtor/, in response to MOG presented by
DCs. Similar to what we already observed (Figure 2C), less
than 5% of the Cd5/Mtor+/+ cells induced Foxp3 expression,
whereas over 60% of Cd5+/+ Mtor+/+ cells became pTreg cells.
We found that deletion of mTOR completely restored the induc-
tion of Cd5/ pTreg cells (Figure 5D). We also observed that,
while a deletion of mTOR had only a limited impact on total
Treg cells in the peripheral lymphoid organs (Figure S5D),
absence of mTOR restored Nrp1lo pTreg cells among Cd5/
CD4+ T cells from the intestinal lamina propria (Figures S5E
and S5F). Thus under in vivo conditions T cells rely on internal
mechanisms to counter mTOR-mediated functions and CD5
blocks mTOR during the in vivo induction of pTreg cells.
DISCUSSION
We have identified a crucial mechanism by which induction
of extrathymic Treg cells is determined by CD5 in T cells. CD5
promotes the development of Treg cells by blocking mTOR-
dependent signals induced by effector-differentiating cytokines
to inhibit Treg cell induction. Therefore, CD5 determines T cell
fate by facilitating Treg cell conversion from T cells that have re-
sponded to either high affinity self-pMHC in thymus or to toleriz-
ing antigens presented by peripheral DCs.
The extrathymic induction of Foxp3+ Treg cells requires T cell
activation in an appropriate environment. TGF-b and other path-
ways augment Treg cell conversion, whereas cytokines such as
IL-4, IL-6, and IFN-g inhibit this process and instead might facil-
itate effector cell differentiation (Arpaia et al., 2013; Dardalhon
et al., 2008; Francisco et al., 2010; Hadjur et al., 2009; Josefo-
wicz et al., 2012a; Josefowicz et al., 2012b; Luo and Li, 2013;
Mathis and Benoist, 2009; Sakaguchi et al., 2013; von Boehmer
and Melchers, 2010; Zhou et al., 2009). However, it remains un-
clear how such diverse extrinsic signals can be integrated and
controlled on a level of individual T cells to specifically promote
conversion into Treg cells of self-reactive peripheral T cells.
CD5 (Ly-1, Leu-1) is a 67-kD type I cell-surface protein with
a large cytoplasmic domain that recruits positive and negative
regulators of T cell and B cell signaling (Soldevila et al., 2011).Immunity 42, 471–483, March 17, 2015 ª2015 Elsevier Inc. 477
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Figure 4. Inhibition of mTOR Restores Induction of Treg Cells in the Absence of CD5 Functions
(A) Immunoblot analysis of STAT3 phosphorylation (p-) at Y705 in lysates of CD5hi, CD5lo, and Cd5/ naive CD4+ cells stimulated under Treg cell-differentiation
conditions and in the absence or presence of IL-6. Results represent one of two similar experiments.
(B) High CD5 expression relieves the IL-6-mediated inhibition of Treg cell induction within a broad range of TCR stimulation. CD5hi, CD5lo, andCd5/ naive CD4+
cells were cultured under Treg cell-differentiation conditions using varying concentrations of anti-CD3 in either the absence or presence of recombinant IL-6 as
indicated. Plots show Foxp3 (RFP) expression (y axis) and anti-CD25 staining intensity (x axis). Results represent one of two similar experiments.
(legend continued on next page)
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Functions of CD5 in T cells can lead to increased immune re-
sponses by promoting induction and maintenance of Th1 and
Th17 effector T cells through activation of mTOR, as well as by
decreasing tTreg cell functions (Axtell et al., 2006; Dasu et al.,
2008; McGuire et al., 2014; Ordon˜ez-Rueda et al., 2009). Such
diminished effector functions together with enhanced negative
selection of self-reactive T cells in the absence of CD5 explain
why in Cd5/ animals immune and autoimmune responses,
including EAE, are reduced (Axtell et al., 2006; Soldevila et al.,
2011). Moreover, high expression of CD5 contributes to mainte-
nance of IL-2, IL-7, and IL-15-dependent homeostasis of naive
CD8+ T cells by increasing TCR-mediated sensitivity to these
cytokines (Cho et al., 2010). Despite such co-stimulatory func-
tions, CD5 mediates still only partially understood inhibitory
mechanisms (Soldevila et al., 2011). Expression of CD5 is
associated with T cell tolerance and blocking of immune and
autoimmune responses (Fenutrı´a et al., 2014; Hawiger et al.,
2004; Stamou et al., 2003). CD5 also regulates TCR signaling
in thymic development during which it directly influences the
threshold for T cell activation (Azzam et al., 2001; Azzam et al.,
1998; Tarakhovsky et al., 1995). Thymocytes with high affinity
for self-pMHC upregulate CD5 expression, thereby partially
limiting their responses to self and extending the repertoire of
selected TCRs (Azzam et al., 2001; Azzam et al., 1998). Further,
a specific high or low expression of CD5 may indirectly mark
T cells differing in intrinsic changes in TCR signaling pre-deter-
mined by TCR interactions in thymus (Persaud et al., 2014; Ful-
ton et al., 2015).
Although TCR signals affect iTreg cell development, our re-
sults indicate that CD5 controls the initiation of Treg cell induc-
tion by regulating inhibition of this process by cell-differentiating
cytokines within a broad range of TCR stimulation. Multiple
cytokine-induced signals may activate mTOR (Cardoso et al.,
2009; Fang et al., 2006; Kim et al., 2013; Powell et al., 2012).
Consistent with such pathways, we find that a specific role of
CD5 in developing extrathymic Treg cells, both in vitro and
in vivo, depends on blocking activation of mTOR. CD5 can
inhibit PI3K, but negative regulation of mTOR by CD5 has not
been shown directly (Delgoffe et al., 2009; Haxhinasto et al.,
2008; Kang et al., 2008; Ordon˜ez-Rueda et al., 2009; Powell
et al., 2012; Sauer et al., 2008; Soldevila et al., 2011; Thomson
et al., 2009; Zeng et al., 2013). We propose that CD5 promotes
Treg cell differentiation by blocking mTOR-mediated inhibition(C) Inefficient pTreg cell induction in the absence of CD5. Cd5+/+ and Cd5/ 2D
treated with either 15 mg/mouse or 5 mg/mouse of aDEC-MOG or PBS. Plots sh
expression (y axis) and anti-CD5 staining intensity (x axis) gated on populations
experiments.
(D) Pharmacological inhibitors. Cd5/ naive CD4+ cells were cultured in vitro u
absence or presence of the indicated pharmacological inhibitors. Plots show Fo
represent one of two similar experiments.
(E) S6K phosphorylation. Immunoblot analysis of p70 S6K phosphorylation (p-) at
under Treg cell-differentiation conditions and in the absence or presence of IL-6
(F) S6 phosphorylation. CD5hi, CD5lo, andCd5/ naive CD4+ cells were cultured u
Overlaid histograms show specific staining with anti-pS6 (S235 and 236) gated on
line- Cd5/, cells) Results represent one of two similar experiments.
(G) Inhibition of a rapamycin-sensitive pathway restores CD5-specific functions to
cultured under Treg cell-differentiation conditions and in the presence or absen
Foxp3 (RFP) expression (y axis), and anti-CD25 staining intensity (x axis) gated o
experiments. (B–D and G) numbers in quadrants indicate corresponding percenof Treg cell induction. These CD5-dependent mechanisms
involve a regulation of PI3K, Akt, and possibly other signaling
mediators to block signals initiated by cytokine receptors
(Soldevila et al., 2011). In contrast, in other peripheral lympho-
cytes including Th17 T cells, specific CD5 interactions with
mediators such as casein kinase 2 (CK2), can enhance mTOR
activation induced by the TCR engagement (McGuire et al.,
2014).
The elevated expression of CD5 persists in mature peripheral
T cells and an increased expression of CD5 serves in peripheral
CD4+ T cells as an indicator of self-reactivity in the polyclonal
T cell repertoire (Klein et al., 2014; Mandl et al., 2013; Persaud
et al., 2014; Stritesky et al., 2012). Despite functions of CD5 as
a negative regulator of TCR signaling in thymus, the potentially
autoaggressive self-reactive CD5hi T cells remain responsive to
antigenic stimulation (Klein et al., 2014; Mandl et al., 2013; Per-
saud et al., 2014). Under pro-inflammatory conditions CD5hi
T cells can give rise to effector T cells that cross-react with
foreign epitopes (Mandl et al., 2013; Persaud et al., 2014; Zhao
and Davies, 2010). Therefore, despite harboring self-reactive
cells, the CD5hi T cell population actively contributes to specific
immune responses thereby risking development of cross-reac-
tive anti-self-responses.
Our findings show that CD5 directly functions to program the
induction of Treg cells from T cells that upregulated their CD5
expression in response to self-pMHC in thymus or tolerizing
antigens in the periphery. Therefore CD5 links such tolerogenic
signals with extrathymic Treg cell development, and we propose
that this mechanism might mitigate cross-reactive anti-self-
responses. These functions of CD5 differ from the CD5-indepen-
dent process of tTreg cell development in thymus (Ordon˜ez-
Rueda et al., 2009). We find that upon exposure to Treg
cell-differentation signals such as TGF-b, CD5hi T cells develop
efficiently into Treg cells even under suboptimal cytokine condi-
tions including the presence of effector-differentiating cytokines
IL-4, IL-6, or IFN-g. In contrast, such effector-differentiating
cytokines inhibit Treg cell conversion of CD5lo T cells, as well
as theCd5/ T cells that are prevented from efficient conversion
into pTreg cells in vivo. Therefore a preferential conversion into
Treg cells of CD5hi cells focusesmechanisms of antigen-specific
tolerance on self-reactive T cells to prevent possible autoim-
mune responses. In contrast, a blockade of Treg cell conversion
in low-affinity CD5lo T cells might potentially help to strengthen2 TCR tg Foxp3negCD25neg T cells were adoptively transferred into recipients
ow lymph node cells analyzed by flow cytometry after 11 days, Foxp3 (RFP)
of adoptively transferred CD4+ T cells. Results represent one of two similar
nder Treg cell-differentiation conditions and with addition of IL-6 in either the
xp3 (RFP) expression (y axis) and anti-CD25 staining intensity (x axis). Results
T421 and S424 in lysates of CD5hi, CD5lo, and Cd5/ naive T cells stimulated
. Results represent one of two similar experiments.
nder Treg cell-differentiation conditions and in the presence of IL-6 for 2 or 3 hr.
indicated populations of cultured cells (red line- CD5hi, blue line- CD5lo, orange
promote Treg cell induction. CD5hi, CD5lo, and Cd5/ naive CD4+ cells were
ce of effector supernatants and with or without added rapamycin. Plots show
n indicated populations of cultured cells. Results represent one of two similar
tages.
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Figure 5. High Expression of CD5 in T Cells Blocks mTOR Functions that Mediate Inhibition of Treg Cell Induction
(A–C) Deletion of mTOR restores CD5-specific functions to mediate iTreg cell induction. Mtor/and Mtor+/+ CD5hi, CD5lo, and Cd5/ naive CD4+ cells were
cultured under Treg cell-differentiation conditions and in either the absence or presence of IL-4 (A), IL-6 (B), and IFN-g (C). Graphs show percentages of
Foxp3+CD25+ cells in the indicated groups of cells. Each result shown in (A–C) representsmean ± SEM from three independent experiments. *p < 0.05, **p < 0.01,
***p < 0.001, and ****p < 0.0001 determined by two-way ANOVA with multiple comparisons determined by Tukey’s test.
(D) mTOR interferes with the in vivo induction of pTreg cells in the absence of CD5.Mtor+/+ andMtor/ Cd5+/+ and Cd5/ 2D2 TCR tg Foxp3negCD25neg T cells
were adoptively transferred into recipients that were then treated with either 15 mg/mouse aDEC-MOG or PBS. Plots show lymph node cells analyzed by flow
cytometry after 18 days, Foxp3 (RFP) expression (y axis) and anti-CD25 staining intensity (x axis) gated on populations of adoptively transferred CD4+ T cells.
Numbers in quadrants indicate corresponding percentages and results represent one of two similar experiments.immune responses against non-self. However, some of the
CD5lo T cells can still be highly responsive to innocuous periph-
eral antigens despite their low affinity for self-pMHC in the
thymus. Therefore to further prevent auto-immune responses,
the expression of CD5 might be induced in CD5lo cells following
their response to cognate antigens presented in a tolerogenic
context, thus helping in conversion of such T cells into pTreg
cells. Overall, our results suggest that CD5 can directly shape
a functional repertoire of peripheral T cells by selectively facili-
tating a de novo induction of Treg cells.
In conclusion, an increased expression of CD5 might allow for
a selective de novo induction of Treg cells from T cells that have
responded to high affinity self-pMHC in thymus or tolerizing
antigens in the periphery, while maintaining an overall high plas-
ticity of immune responses among the total T cell repertoire.
EXPERIMENTAL PROCEDURES
Complete experimental procedures can be found in the Supplemental Infor-
mation section.480 Immunity 42, 471–483, March 17, 2015 ª2015 Elsevier Inc.Mice
Cd5/ mice on a C57BL/6 background (Hawiger et al., 2004; Tarakhovsky
et al., 1994), Foxp3RFP mice (Wan and Flavell, 2005) mice, anti-MOG TCR
transgenic (2D2) mice (Bettelli et al., 2003), Mtor Fl/Fl mice (Risson et al.,
2009), and CD4-Cre+/ mice (Lee et al., 2001) were previously described. 6-
to 8-week-old sex- and age-matched littermates were used for all experi-
ments. All mice were maintained in our facility under specific pathogen-free
conditions and used in accordance with the guidelines of Saint Louis Univer-
sity Institutional Animal Care and Use Committee.
Production of Chimeric Antibodies
Chimeric antibodies were produced as previously described (Hawiger et al.,
2001, 2004). Antibodies were expressed in A293T cells by transient transfec-
tion using calcium-phosphate method. Cells were grown in serum free
DMEM supplemented with Nutridoma SP (Roche), and antibodies were puri-
fied on protein-G columns. Chimeric antibodies were injected in PBS
intraperitoneally.
Antibodies
The following antibodieswere used for cell staining: anti-CD25 (PL61), anti-CD4
(GK1.5), anti-CD45.1 (A20), anti-CD44 (IM7), anti-CD62L (Mel-14), anti-CD5
(53-7.3) anti-IL-4 (11B11), anti-IL17 (TC11-18 H10.1), anti-IFN-g (XMG1.2),
anti-Helios (22F6), anti-Foxp3 (FJK-16 s) from Biolegend, anti-P-S6-S235
and 236 (D57.2.2E), anti-STAT3 (79D7), anti-P-STAT3(Y705) (D3A7), anti-P-
AKT(S473), anti-P-AKT(T308) (D25E6), anti-AKT (C67E7), anti-P-S6K(S371),
anti-P-S6K(T421 and S424), anti-S6K (49D7), anti-b-actin (D6A8) from Cell
Signaling, anti-CD45 (LY-5), anti-Tbet (4B10) from eBioscience, anti-RORgt
(q31-378) from BD, polyclonal anti-Nrp1 from R&D Systems.
Flow Cytometry, Adoptive Transfers, and Cell Cultures
LN and spleen cells from 5–10 mice per each experimental group were pooled
and T cells were enriched by negative (CD8 B220CD11bCD11cNK1.1)
or positive (CD4+) selection usingmagnetic microbeads (Miltenyi) and then cell
sorted on ARIA III (BD).
Unless stated otherwise, all in vitro Treg cell differentiation conditions
included TGF-b at a concentration of 1 ng/mL and cells were cultured for
5 days and included addition of IL-4 (9 ng/mL), IL-6 (8 ng/mL), or IFN-g
(5 ng/mL) or effector supernatants and Rapamycin (50 nM).
Immunoblot Analysis
Naive sorted CD4+ T cells were stimulated in Treg cell-skewing conditions with
or without 9 ng/mL IL-4, 8 ng/mL IL-6, or 5 ng/mL IFN-g for 2 hr and then
collected and lysed.
EAE Model
To induce EAE 7- to 8-week-old mice were injected with 100 mg of synthetic
Myelin Oligodendrocyte Glycoprotein peptide (MOG35–55, Yale Keck Protein
Synthesis Facility) in Complete Freund’s Adjuvant (Difco) subcutaneously in
each flank. CFA was enriched with Mycobacterium tuberculosis (10 ml
CFA + 40 mgM. tuberculosis from Difco). Pertussis Toxin (List Biological Lab-
oratories Inc.) was injected 200 ng per mouse in PBS intraperitoneally on days
0 and 2 after MOG35–55 injections. Clinical score of EAE was graded on a scale
of 1–4: 0, no clinical signs; 1, flaccid tail; 2, hind limb weakness, abnormal gait;
3, complete hind limb paralysis; 4, complete hind limb paralysis and forelimb
weakness or paralysis. Mice were scored daily. Each experimental group
was scored in a blinded fashion.
Isolation of Lamina Propria Cells
Large intestines were excised from 8- to 12-week-old mice and intraepithelial
lymphocytes were removed. Tissues were digested with a mixture of collage-
nase type VIII and DNase I (both from Sigma). Cells were stained for CD45,
CD4, CD25, and Nrp1 and analyzed on LSR II (BD).
Statistical Analysis
For EAE experiments, mice of particular genotypes were randomly assigned to
individual experimental groups. All experimental groups and individual mice
were included in statistical analysis. The number of groups and mice in each
group was determined to achieve statistical significance based on a
commonly used statistical technique, two-way ANOVA, and EAE data was
analyzed using linear regression with the 95% confidence interval (C.I.). For
other experiments, datawas pooled from two to four independent experiments
and tested using two-way ANOVA, Student’s t test, and Tukey’s honest signif-
icant difference (Tukey’s HSD) test among corresponding experimental
groups.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2015.02.010.
AUTHOR CONTRIBUTIONS
J.G.H. designed and performed experiments, interpreted data, and wrote the
manuscript. A.O. designed and performed EAE experiments and immuno-
blotting and wrote the manuscript. A.J. designed and performed EAE exper-
iments and wrote the manuscript. C.G. maintained experimental animals and
participated in preparation of experiments and manuscript. D.H. conceived,
designed, and oversaw experiments, interpreted data, and wrote the
manuscript.ACKNOWLEDGMENTS
The authors would like to thank Dr. Richard Flavell (Yale University) for
providing some of the experimental mice, Joy Eslick and Sherri L. Koehm
(Saint Louis University) for expert help with flow cytometry, and Ziva Misulovin
(Saint Louis University) for help with immunoblots. This work was supported in
part by National Multiple Sclerosis Society career transition fellowship (TA
3024A) and internal funds provided by the Saint Louis University (all to D.H.).
Received: August 18, 2014
Revised: November 17, 2014
Accepted: February 20, 2015
Published: March 17, 2015
REFERENCES
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu,
H., Cross, J.R., Pfeffer, K., Coffer, P.J., andRudensky, A.Y. (2013). Metabolites
produced by commensal bacteria promote peripheral regulatory T-cell gener-
ation. Nature 504, 451–455.
Axtell, R.C., Xu, L., Barnum, S.R., and Raman, C. (2006). CD5-CK2 binding/
activation-deficient mice are resistant to experimental autoimmune encepha-
lomyelitis: protection is associated with diminished populations of IL-17-ex-
pressing T cells in the central nervous system. J. Immunol. 177, 8542–8549.
Azzam, H.S., Grinberg, A., Lui, K., Shen, H., Shores, E.W., and Love, P.E.
(1998). CD5 expression is developmentally regulated by T cell receptor
(TCR) signals and TCR avidity. J. Exp. Med. 188, 2301–2311.
Azzam, H.S., DeJarnette, J.B., Huang, K., Emmons, R., Park, C.S., Sommers,
C.L., El-Khoury, D., Shores, E.W., and Love, P.E. (2001). Fine tuning of TCR
signaling by CD5. J. Immunol. 166, 5464–5472.
Barthlott, T., Kassiotis, G., and Stockinger, B. (2003). T cell regulation as a side
effect of homeostasis and competition. J. Exp. Med. 197, 451–460.
Bettelli, E., Pagany, M., Weiner, H.L., Linington, C., Sobel, R.A., and Kuchroo,
V.K. (2003). Myelin oligodendrocyte glycoprotein-specific T cell receptor
transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp.
Med. 197, 1073–1081.
Bhandoola, A., Bosselut, R., Yu, Q., Cowan, M.L., Feigenbaum, L., Love, P.E.,
and Singer, A. (2002). CD5-mediated inhibition of TCR signaling during intra-
thymic selection and development does not require the CD5 extracellular
domain. Eur. J. Immunol. 32, 1811–1817.
Brown, M.H., and Lacey, E. (2010). A ligand for CD5 is CD5. J. Immunol. 185,
6068–6074.
Cardoso, B.A., Martins, L.R., Santos, C.I., Nadler, L.M., Boussiotis, V.A.,
Cardoso, A.A., and Barata, J.T. (2009). Interleukin-4 stimulates proliferation
and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR
signaling. Leukemia 23, 206–208.
Cho, J.H., Kim, H.O., Surh, C.D., and Sprent, J. (2010). T cell receptor-depen-
dent regulation of lipid rafts controls naive CD8+ T cell homeostasis. Immunity
32, 214–226.
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R.A.,
Mitsdoerffer, M., Strom, T.B., Elyaman, W., Ho, I.C., et al. (2008). IL-4 inhibits
TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates
IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 9, 1347–1355.
Dasu, T., Qualls, J.E., Tuna, H., Raman, C., Cohen, D.A., and Bondada, S.
(2008). CD5 plays an inhibitory role in the suppressive function of murine
CD4(+) CD25(+) T(reg) cells. Immunol. Lett. 119, 103–113.
Delgoffe, G.M., Kole, T.P., Zheng, Y., Zarek, P.E., Matthews, K.L., Xiao, B.,
Worley, P.F., Kozma, S.C., and Powell, J.D. (2009). The mTOR kinase differen-
tially regulates effector and regulatory T cell lineage commitment. Immunity 30,
832–844.
Fang, P., Hwa, V., and Rosenfeld, R.G. (2006). Interferon-gamma-induced
dephosphorylation of STAT3 and apoptosis are dependent on the mTOR
pathway. Exp. Cell Res. 312, 1229–1239.
Fenutrı´a, R., Martinez, V.G., Simo˜es, I., Postigo, J., Gil, V., Martı´nez-Florensa,
M., Sintes, J., Naves, R., Cashman, K.S., Alberola-Ila, J., et al. (2014).Immunity 42, 471–483, March 17, 2015 ª2015 Elsevier Inc. 481
Transgenic expression of soluble human CD5 enhances experimentally-
induced autoimmune and anti-tumoral immune responses. PLoS ONE 9,
e84895.
Francisco, L.M., Sage, P.T., and Sharpe, A.H. (2010). The PD-1 pathway in
tolerance and autoimmunity. Immunol. Rev. 236, 219–242.
Fulton, R.B., Hamilton, S.E., Xing, Y., Best, J.A., Goldrath, A.W., Hogquist,
K.A., and Jameson, S.C. (2015). The TCR’s sensitivity to self peptide-MHCdic-
tates the ability of naive CD8(+) T cells to respond to foreign antigens. Nat.
Immunol. 16, 107–117.
Hadjur, S., Bruno, L., Hertweck, A., Cobb, B.S., Taylor, B., Fisher, A.G., and
Merkenschlager, M. (2009). IL4 blockade of inducible regulatory T cell differen-
tiation: the role of Th2 cells, Gata3 and PU.1. Immunol. Lett. 122, 37–43.
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch,
J.V., Steinman, R.M., and Nussenzweig, M.C. (2001). Dendritic cells induce
peripheral T cell unresponsiveness under steady state conditions in vivo.
J. Exp. Med. 194, 769–779.
Hawiger, D., Masilamani, R.F., Bettelli, E., Kuchroo, V.K., and Nussenzweig,
M.C. (2004). Immunological unresponsiveness characterized by increased
expression of CD5 on peripheral T cells induced by dendritic cells in vivo.
Immunity 20, 695–705.
Haxhinasto, S., Mathis, D., and Benoist, C. (2008). The AKT-mTOR axis regu-
lates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565–574.
Hill, J.A., Hall, J.A., Sun, C.M., Cai, Q., Ghyselinck, N., Chambon, P., Belkaid,
Y., Mathis, D., and Benoist, C. (2008). Retinoic acid enhances Foxp3 induction
indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29,
758–770.
Idoyaga, J., Fiorese, C., Zbytnuik, L., Lubkin, A., Miller, J., Malissen, B.,
Mucida, D., Merad, M., and Steinman, R.M. (2013). Specialized role of migra-
tory dendritic cells in peripheral tolerance induction. J. Clin. Invest. 123,
844–854.
Josefowicz, S.Z., Lu, L.F., and Rudensky, A.Y. (2012a). Regulatory T cells:
mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–564.
Josefowicz, S.Z., Niec, R.E., Kim, H.Y., Treuting, P., Chinen, T., Zheng, Y.,
Umetsu, D.T., and Rudensky, A.Y. (2012b). Extrathymically generated regula-
tory T cells control mucosal TH2 inflammation. Nature 482, 395–399.
Kang, J., Huddleston, S.J., Fraser, J.M., and Khoruts, A. (2008). De novo in-
duction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells in vivo
following systemic antigen administration accompanied by blockade of
mTOR. J. Leukoc. Biol. 83, 1230–1239.
Kassiotis, G., Zamoyska, R., and Stockinger, B. (2003). Involvement of avidity
for major histocompatibility complex in homeostasis of naive and memory
T cells. J. Exp. Med. 197, 1007–1016.
Kim, H.Y., Jhun, J.Y., Cho, M.L., Choi, J.Y., Byun, J.K., Kim, E.K., Yoon, S.K.,
Bae, S.H., Chung, B.H., and Yang, C.W. (2013). Interleukin-6 upregulates Th17
response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver fail-
ure. J. Gastroenterol. 49, 1264–1273.
Klein, L., Kyewski, B., Allen, P.M., and Hogquist, K.A. (2014). Positive and
negative selection of the T cell repertoire: what thymocytes see (and don’t
see). Nat. Rev. Immunol. 14, 377–391.
Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M.C.,
and von Boehmer, H. (2005). Inducing and expanding regulatory T cell popu-
lations by foreign antigen. Nat. Immunol. 6, 1219–1227.
Lee, P.P., Fitzpatrick, D.R., Beard, C., Jessup, H.K., Lehar, S., Makar, K.W.,
Pe´rez-Melgosa, M., Sweetser, M.T., Schlissel, M.S., Nguyen, S., et al.
(2001). A critical role for Dnmt1 and DNA methylation in T cell development,
function, and survival. Immunity 15, 763–774.
Luo, C.T., and Li, M.O. (2013). Transcriptional control of regulatory T cell devel-
opment and function. Trends Immunol. 34, 531–539.
Mandl, J.N., Monteiro, J.P., Vrisekoop, N., and Germain, R.N. (2013). T cell-
positive selection uses self-ligand binding strength to optimize repertoire
recognition of foreign antigens. Immunity 38, 263–274.
Mathis, D., and Benoist, C. (2009). Aire. Annu. Rev. Immunol. 27, 287–312.
McGuire, D.J., Rowse, A.L., Li, H., Peng, B.J., Sestero, C.M., Cashman, K.S.,
De Sarno, P., and Raman, C. (2014). CD5 enhances Th17-cell differentiation by482 Immunity 42, 471–483, March 17, 2015 ª2015 Elsevier Inc.regulating IFN-g response and RORgt localization. Eur. J. Immunol. 44, 1137–
1142.
Ordon˜ez-Rueda, D., Lozano, F., Sarukhan, A., Raman, C., Garcia-Zepeda,
E.A., and Soldevila, G. (2009). Increased numbers of thymic and peripheral
CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling. Eur. J. Immunol.
39, 2233–2247.
Perez-Villar, J.J., Whitney, G.S., Bowen, M.A., Hewgill, D.H., Aruffo, A.A., and
Kanner, S.B. (1999). CD5 negatively regulates the T-cell antigen receptor
signal transduction pathway: involvement of SH2-containing phosphotyrosine
phosphatase SHP-1. Mol. Cell. Biol. 19, 2903–2912.
Persaud, S.P., Parker, C.R., Lo, W.L., Weber, K.S., and Allen, P.M. (2014).
Intrinsic CD4+ T cell sensitivity and response to a pathogen are set and sus-
tained by avidity for thymic and peripheral complexes of self peptide and
MHC. Nat. Immunol. 15, 266–274.
Powell, J.D., Pollizzi, K.N., Heikamp, E.B., and Horton, M.R. (2012). Regulation
of immune responses by mTOR. Annu. Rev. Immunol. 30, 39–68.
Risson, V., Mazelin, L., Roceri, M., Sanchez, H., Moncollin, V., Corneloup, C.,
Richard-Bulteau, H., Vignaud, A., Baas, D., Defour, A., et al. (2009). Muscle
inactivation of mTOR causes metabolic and dystrophin defects leading to se-
vere myopathy. J. Cell Biol. 187, 859–874.
Sakaguchi, S., Vignali, D.A., Rudensky, A.Y., Niec, R.E., and Waldmann, H.
(2013). The plasticity and stability of regulatory T cells. Nat. Rev. Immunol.
13, 461–467.
Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., Knight,
Z.A., Cobb, B.S., Cantrell, D., O’Connor, E., et al. (2008). T cell receptor
signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl.
Acad. Sci. USA 105, 7797–7802.
Sen, G., Bikah, G., Venkataraman, C., and Bondada, S. (1999). Negative regu-
lation of antigen receptor-mediated signaling by constitutive association of
CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur. J.
Immunol. 29, 3319–3328.
Sestero, C.M., McGuire, D.J., De Sarno, P., Brantley, E.C., Soldevila, G.,
Axtell, R.C., and Raman, C. (2012). CD5-dependent CK2 activation pathway
regulates threshold for T cell anergy. J. Immunol. 189, 2918–2930.
Soldevila, G., Raman, C., and Lozano, F. (2011). The immunomodulatory prop-
erties of the CD5 lymphocyte receptor in health and disease. Curr. Opin.
Immunol. 23, 310–318.
Stamou, P., de Jersey, J., Carmignac, D., Mamalaki, C., Kioussis, D., and
Stockinger, B. (2003). Chronic exposure to low levels of antigen in the periph-
ery causes reversible functional impairment correlating with changes in CD5
levels in monoclonal CD8 T cells. J. Immunol. 171, 1278–1284.
Stern, J.N., Keskin, D.B., Kato, Z.,Waldner, H., Schallenberg, S., Anderson, A.,
von Boehmer, H., Kretschmer, K., and Strominger, J.L. (2010). Promoting
tolerance to proteolipid protein-induced experimental autoimmune encepha-
lomyelitis through targeting dendritic cells. Proc. Natl. Acad. Sci. USA 107,
17280–17285.
Stritesky, G.L., Jameson, S.C., and Hogquist, K.A. (2012). Selection of self-
reactive T cells in the thymus. Annu. Rev. Immunol. 30, 95–114.
Tarakhovsky, A., Mu¨ller,W., andRajewsky, K. (1994). Lymphocyte populations
and immune responses in CD5-deficient mice. Eur. J. Immunol. 24, 1678–
1684.
Tarakhovsky, A., Kanner, S.B., Hombach, J., Ledbetter, J.A., Mu¨ller, W.,
Killeen, N., and Rajewsky, K. (1995). A role for CD5 in TCR-mediated signal
transduction and thymocyte selection. Science 269, 535–537.
Thomson, A.W., Turnquist, H.R., and Raimondi, G. (2009). Immunoregulatory
functions of mTOR inhibition. Nat. Rev. Immunol. 9, 324–337.
Verhoef, A., Alexander, C., Kay, A.B., and Larche´, M. (2005). T cell epitope
immunotherapy induces a CD4+ T cell population with regulatory activity.
PLoS Med. 2, e78.
von Boehmer, H., and Melchers, F. (2010). Checkpoints in lymphocyte devel-
opment and autoimmune disease. Nat. Immunol. 11, 14–20.
Wan, Y.Y., and Flavell, R.A. (2005). Identifying Foxp3-expressing suppressor
T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102, 5126–
5131.
Weiss, J.M., Bilate, A.M., Gobert, M., Ding, Y., Curotto de Lafaille, M.A.,
Parkhurst, C.N., Xiong, H., Dolpady, J., Frey, A.B., Ruocco, M.G., et al.
(2012). Neuropilin 1 is expressed on thymus-derived natural regulatory
T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med.
209, 1723–1742.
Yadav, M., Louvet, C., Davini, D., Gardner, J.M., Martinez-Llordella, M.,
Bailey-Bucktrout, S., Anthony, B.A., Sverdrup, F.M., Head, R., Kuster, D.J.,
et al. (2012). Neuropilin-1 distinguishes natural and inducible regulatory
T cells among regulatory T cell subsets in vivo. J. Exp. Med. 209, 1713–
1722, S1711-1719.
Yogev, N., Frommer, F., Lukas, D., Kautz-Neu, K., Karram, K., Ielo, D., von
Stebut, E., Probst, H.C., van den Broek, M., Riethmacher, D., et al. (2012).Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeo-
stasis of PD-1 receptor(+) regulatory T cells. Immunity 37, 264–275.
Zeng, H., Yang, K., Cloer, C., Neale, G., Vogel, P., and Chi, H. (2013). mTORC1
couples immune signals and metabolic programming to establish T(reg)-cell
function. Nature 499, 485–490.
Zhao, C., and Davies, J.D. (2010). A peripheral CD4+ T cell precursor for naive,
memory, and regulatory T cells. J. Exp. Med. 207, 2883–2894.
Zheng, M., Xing, C., Xiao, H., Ma, N., Wang, X., Han, G., Chen, G., Hou, C.,
Shen, B., Li, Y., and Wang, R. (2014). Interaction of CD5 and CD72 is involved
in regulatory T and B cell homeostasis. Immunol. Invest. 43, 705–716.
Zhou, L., Chong, M.M., and Littman, D.R. (2009). Plasticity of CD4+ T cell line-
age differentiation. Immunity 30, 646–655.Immunity 42, 471–483, March 17, 2015 ª2015 Elsevier Inc. 483
